Catalog Products » Catalog Peptide » SARS-CoV-2 Spike Glycoprotein B.1.617.1-Kappa
Manual
COAs
HPLC
MS

SARS-CoV-2 Spike Glycoprotein B.1.617.1-Kappa

This pool is delivered in two subpools of 158 & 158 peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Spike glycoprotein of SARS-CoV-2 B.1.617.1 (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.617.1, India, Kappa) covering the following mutations: T0095I, G0142D, E0154K, L0452R, E0484Q, D0614G, P0681R and Q1071H.
$716.00
RP30031

Ask us a question
Description

This pool is delivered in two subpools of 158 & 158 peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Spike glycoprotein of SARS-CoV-2 B.1.617.1 (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.617.1, India, Kappa) covering the following mutations: T0095I, G0142D, E0154K, L0452R, E0484Q, D0614G, P0681R and Q1071H.
Note

The peptides of this product are supplied as trifluoroacetate salts.

Properties
Source Severe Acute Respiratory Syndrome-related coronavirus 2 (Spike B.1.617.1) Spike glycoprotein (covering the following mutations: T0095I, G0142D, E0154K, L0452R, E0484Q, D0614G, P0681R and Q1071H).
Gene ID S
Length 1273 aa
Purity Crude (Major peak by ESI-MS is guaranteed to be peptide of interest - determined at 220 nm for each individual peptide).
Solubility Dissolve in a minimum amount of pure DMSO (approx. 40 µl) and dilute with PBS buffer to the final concentration. Please note that the final concentration of DMSO must be below 1 % (v/v) to avoid toxicity in the biological system.
Storage Store at -20°C.
Back

Please note that we do not provide HPLC and MS reports for each individual peptide within our peptide library products.